Thoratec Beats on Q2 Earnings & Revenues, Pipeline Strong
Thoratec Corp. THOR reported second-quarter 2015 adjusted earnings of 25 cents per share (including share-based compensation), which outpaced the Zacks Consensus Estimate of 14 cents but declined 13.8% on a year-over-year basis, primarily due to higher operating expenses. !function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^https:/.test(d.location)?’https’:’http’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+”://cdn1.findthebest.com/rx/widgets.js”;fjs.parentNode.insertBefore(js,fjs);}}(document,”script”,”ftb-widgetjs”); The Quarter in Details Product sales increased 9% on a year-over-year basis to $128.7 million, which steered past the Zacks Consensus Estimate of $115 million […]